City

Moscow (1)

Saint Petersburg (1)

Condition

Chronic Hepatitis C Genotype 1 (1)

Chronic Hepatitis c Genotype 1 (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Merck Sharp & Dohme Corp. (1)

R-Pharm (1)

Collaborator

Almedis (1)

ChromSystemsLab (1)

Scientific Center EFiS (1)

Intervention

boceprevir (1)

narlaprevir (1)

peginterferon alfa-2b (1)

placebo (1)

ribavirin (1)

ritonavir (1)

sofosbuvir (1)

Study Documents

CSR Synopsis (1)

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

chronic hepatitis c genotype 1

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

Completed

Chronic Hepatitis c Genotype 1

Narlaprevir
+2 more

Moscow, Russian Federation
+4 more

Oct 27, 2022

Chronic Hepatitis C Genotype 1 Trial (Boceprevir, Placebo, peginterferon alfa-2b)

Completed

Has Results

Chronic Hepatitis C Genotype 1

Boceprevir
+3 more

(no location specified)

Jan 15, 2021